Mylan's generic of migraine drug Imitrex gets FDA nod

08/10/2009 | Forbes

Mylan received FDA approval for its generic version of GlaxoSmithKline's migraine drug Imitrex at 25, 50 and 100 milligrams. The company has started shipping the drug.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Mylan Inc.
Washington, DC
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director of Actuarial Services, Government Programs
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA